Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label placebo for functional dyspepsia
NCT03745781Phase 1Terminated
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Dec 2018
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Placebo-COD Research Private Ltd in functional dyspepsia (FD) (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Dyspepsia severity on a Visual Analog Scale at 3 weeks. Started Dec 2018; status: terminated.
02
Drugs
Placebo-COD Research Private Ltd
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT03745781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03745781.